Expert reviewed • 08 January 2025 • 6 minute read
Genetic diseases are non-infectious disorders originating from changes in DNA. These alterations can be at the level of entire chromosomes or single genes, influencing health in diverse populations and age groups.
Changes in chromosome number, structure, or mosaicism can result in conditions like Down Syndrome (Trisomy 21) or Cri du Chat Syndrome. Such disorders often arise from errors in meiosis, leading to missing, extra, or rearranged genetic material.
Type | Mechanism | Examples | Characteristics |
---|---|---|---|
Numerical | Change in chromosome number | Down Syndrome (Trisomy 21) | Extra or missing chromosomes |
Structural | Altered chromosome structure | Cri du Chat Syndrome | Deleted, duplicated segments |
Mosaicism | Mixed cell populations | Mosaic Turner Syndrome | Different genetic makeup in cells |
These disorders follow inheritance patterns like autosomal dominant (Huntington’s disease), autosomal recessive (Cystic Fibrosis), or X-linked (Haemophilia). A single gene mutation can profoundly affect protein function.
Point mutations can alter a single nucleotide, potentially changing an amino acid (as in Sickle Cell Disease), while frameshift or splice site mutations disrupt entire protein structures.
Many conditions arise from multifactorial inheritance, involving multiple genes and environmental factors. Disorders like Type 2 diabetes or heart disease result from gene-environment interactions. Epigenetic changes—such as DNA methylation or histone modification—further complicate these patterns.
Disease | Genetic Factors | Environmental Factors | Risk Factors |
---|---|---|---|
Type 2 Diabetes | Multiple gene variants | Diet, exercise, obesity | Family history, lifestyle |
Heart Disease | Lipid metabolism genes | Diet, smoking, stress | Age, gender, ethnicity |
Autism | Neurodevelopmental genes | Environmental exposures | Parental age, complications |
Genetic diseases can affect multiple systems. For example, Huntington’s disease targets the nervous system, Marfan Syndrome the cardiovascular system, and Cystic Fibrosis the respiratory system. Metabolic disorders like Phenylketonuria impact how cells process substrates.
Modern diagnosis uses cytogenetic analysis (karyotyping, FISH), molecular tests (DNA sequencing, PCR), and biochemical assays (enzyme or metabolite tests). These techniques help identify the genetic basis and guide treatment planning.
Traditional treatments often involve managing symptoms, dietary changes, or enzyme replacement therapies. Emerging methods focus on gene therapy and cell therapy, aiming to correct underlying genetic faults.
Precision medicine tailors interventions to an individual’s genetic profile. Preventive strategies (genetic counselling, preimplantation testing) and population screening can reduce disease incidence, while research advances new treatments, enhancing quality of life.